Wisp has reached 2 million patients nationwide and appointed Keira Krausz as Chief Executive Officer as the women’s telehealth company expands beyond sexual and reproductive health into fertility, diagnostics, menopause and other areas of women’s healthcare.
The milestone marks a new phase for Wisp, which has spent the past eight years building a direct-to-consumer telehealth business focused primarily on sexual and reproductive care.
The company is now broadening its platform from episodic treatments such as STI and UTI care into longer-term health and wellness services designed to support women across different ages and life stages.
Wisp’s expanding offering includes prescription care, menopause treatment, skincare, over-the-counter products developed for women’s health needs, vaginal probiotics, supplements and diagnostic services.
The company is also increasing its focus on at-home testing and personalized treatment plans, with the broader goal of becoming a healthcare destination women can return to repeatedly rather than only when they need treatment for an acute condition.
Wisp currently provides telehealth services across all 50 states and is positioning its platform around 24/7 access, home-based diagnostics and care designed to reduce the friction and stigma that can accompany women’s healthcare.
The company said its long-term strategy is to support patients through multiple healthcare transitions, ranging from birth control and reproductive care to fertility and midlife hormonal changes associated with perimenopause and menopause.
Krausz takes over leadership as Wisp moves from a more narrowly focused sexual and reproductive health company toward a broader women’s health platform.
She brings direct-to-consumer experience and a background scaling companies in the women’s wellness market.
Under Krausz, Wisp plans to continue expanding its presence across sexual and reproductive health while developing additional services around diagnostics, at-home testing, perimenopause and menopause.
The strategy is based on the company’s view that women’s health needs are interconnected rather than isolated. A patient using Wisp for birth control or infection treatment may later need diagnostics, supplements, fertility-related services or treatment related to hormonal changes.
Wisp wants to reduce the need for women to repeatedly begin new relationships with separate providers or healthcare systems as those needs change.
The company is instead developing a platform designed to evolve alongside patients and make different types of care available through a consistent digital experience.
Reaching 2 million patients gives Wisp a substantial existing patient base from which it can introduce those additional products and services as it expands into longer-term care.
Wisp describes itself as the largest pure-play women’s telehealth provider in the U.S. Its services currently span areas including birth control, fertility, menopause, STI testing and at-home diagnostics.
The company is majority-owned by WELL Health Technologies and has also been recognized by Inc., TIME and Clio for its business, product and health equity initiatives.
KEY QUOTES:
“Two million patients is proof that women are looking for a fundamentally different healthcare experience – one that takes them seriously, fits into their lives, and doesn’t make them jump through hoops to get the care they need. Wisp has already changed the way millions of women access sexual and reproductive care. Now, we have an opportunity to bring that same experience to more of women’s health and build a platform that can be there for them not just for one moment, but for decades.”
Keira Krausz, CEO of Wisp
